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In 785 mother-child (50% male) pairs from a longitudinal epidemiological birth cohort, we 
investigated associations between inflammation-related epigenetic polygenic risk scores (i-
ePGS), environmental exposures, cognitive function and child and adolescent internalising 
and externalising problems. We examined prenatal and postnatal effects. For externalising 
problems, one prenatal effect was found: i-ePGS at birth associated with higher externalising 
problems (ages 7-15) indirectly through lower cognitive function (age 7). For internalising 
problems, we identified two effects. For a prenatal effect, i-ePGS at birth associated with 
higher internalising symptoms via continuity in i-ePGS at age 7. For a postnatal effect, higher 
postnatal adversity exposure (birth through age 7) associated with higher internalising 
problems (ages 7-15) via higher i-ePGS (age 7). Hence, externalising problems were related 
mainly to prenatal effects involving lower cognitive function, whereas internalising problems 
appeared related to both prenatal and postnatal effects. The present study supports a link 
between i-ePGS and child and adolescent mental health.  
 
KEY WORDS: ALSPAC, inflammation, attention deficit hyperactivity; conduct disorder, 
oppositional defiant disorder; depression; anxiety; DNA methylation; polyepigenetic score; 
prenatal adversity; postnatal adversity  
  
  





Children who experience adversities (e.g. poverty, caregiver psychopathology, low social 
support, harsh parenting) are at risk of developing persisting stress-related psychiatric 
disorders that can span externalising and internalising problems (Barker, Walton, & Cecil, 
2017). Research has examined multiple possible mediating mechanisms for these 
associations; stress physiology has received the bulk of this attention (O'connor, Moynihan, 
& Caserta, 2014).  In the current study we consider an alternative mechanism, namely, 
inflammation (Dantzer, O’Connor, Freund, Johnson, & Kelley, 2008). The “hidden wounds 
hypothesis” (Danese & Baldwin, 2017; Miller & Chen, 2013) proposes that early 
psychosocial adversity translates into biological risk for mental illness by affecting the 
regulation of the immune system at sensitive stages of brain development (Danese & Lewis, 
2016; Nusslock & Miller, 2016). Recent evidence suggests that DNA methylation, a type of 
epigenetic modification that regulates gene expression, may be a biological mechanism by 
which adversity can result in low-grade inflammation (McDade et al., 2017). However, little 
is known about how adversity in different developmental periods may affect immune-related 
DNA methylation which could affect neurodevelopmental and mental health problems. This 
study examines the concerted influences of pre- and postnatal adversity, an immune-related 
DNA methylation biomarker, and cognitive function (a proxy for brain function) on the 
development of mental health problems from childhood to adolescence.  
Prenatal adversity, inflammation and cognitive function  
During the prenatal period, larger immune molecules (e.g. cytokines, antibodies) may 
have access to the developing fetal brain via the blood brain barrier (BBB; Goasdoué, Miller, 
Colditz, & Bjorkman, 2016). There is good evidence in animal studies, and increasing 
evidence in humans, that inflammation in the mother during pregnancy can affect several 
highly orchestrated, and hence vulnerable, aspects of fetal brain development (Knuesel et al., 
2014). A possible mechanism for brain and behavioural abnormalities following maternal 
immune activation includes the downstream effects of cytokines and other mediators of 
inflammation (e.g. glucocorticoids) on neural plasticity. Here, cytokines and antibodies 
interact with various neural and non-neural cell types (e.g. microglia) and play an important 
role in brain developmental processes, such as synapse modelling, neurogenesis and 
neurotransmission that underlie cognitive and behavioral development (Danese & Lewis, 
2016).  
  In humans, maternal immune activation is associated with increased serum levels of 
pro-inflammatory cytokines (Andersson et al., 2016; Coussons-Read, Okun, & Nettles, 
  




2007). Higher levels of inflammatory makers, such as C-reactive protein (CRP) at birth (cord 
blood) – a sensitive marker of low-grade chronic inflammation – can signpost a range of 
obstetric risks including amniotic fluid infection (Yoon et al., 2000), neonatal sepsis (Joram 
et al., 2006) and predict neurologic impairment in preterm infants (Kaukola et al., 2006). 
Furthermore, a study reported that placental indicators of inflammation in preterm 
newborns associated with variation in messenger RNA expression of genes that, in turn, 
predicted cognitive impairment at 10 years of age (Tilley et al., 2017).  As animal models 
show that maternal immune activation can associate with prenatal adversity (Babri, Doosti, & 
Salari, 2014), these data may be consistent with a wide-range of studies that have highlighted 
the relationship of prenatal adversity with subsequent impaired child cognitive function 
(Barker, Kirkham, Ng, & Jensen, 2013; Jensen, Dumontheil, & Barker, 2014). Of note, 
variation in cognitive function has been linked to both internalising and externalising 
problems (Rock, Roiser, Riedel, & Blackwell, 2014; Séguin, Nagin, Assaad, & Tremblay, 
2004).  
Inflammation and cognitive function  
   After birth, peripheral inflammation can induce neuroinflammation (Dantzer et al., 
2008) and modulate the continued development and function of the brain (Danese & Lewis, 
2016). There are several pathways that link the peripheral and the brain immune systems 
(Dantzer et al., 2008). Peripheral cytokines can stimulate afferent fibers of the vagus nerve, 
which in turn can stimulate cytokine production within the brain. Cytokines can also cross 
into the brain where the BBB is permeable or leaky, or engage surface receptors on astrocytes 
and endothelial cells that form the BBB. Animal research suggests that the immune system 
modulates synaptogenesis, synaptic refinement and survival, as well as myelination via its 
role as a modulator of oligodendrocyte function (Danese & Lewis, 2016; Nusslock & Miller, 
2016).  Moreover, animal research suggests that early life immune activation can bias 
microglia (CNS resident macrophage cells) towards an aggressive inflammatory response and 
reduce glucocorticoid sensitivity (Frank, Hershman, Weber, Watkins, & Maier, 2014).  
In humans, adversity-related infection and low-grade chronic inflammation are 
associated with impaired child cognitive function and language (Jiang et al., 2017; Patrick et 
al., 2005), as well as an increased risk for developing depression in adolescence and 
adulthood (Danese et al., 2011; Danese et al., 2009; Ehrlich, Ross, Chen, & Miller, 2016; 
Miller, Cohen, & Ritchey, 2002) and psychosis in adulthood (Khandaker, Pearson, Zammit, 
Lewis, & Jones, 2014). A recent adult brain imaging study reported that an association 
between higher CRP levels and higher depressive symptoms was mediated by decreased 
  




functional connectivity between the ventromedial prefrontal cortex and the ventral striatum 
and the presupplementary motor cortex (Felger et al., 2016). Hence, animal and human 
research support the idea that adversity-related inflammation can shape neurodevelopment, 
and may also underlie behavioral and emotional disorders 
The potential role of DNA methylation in adversity, inflammation and mental health 
But how might exposure to adversity become biologically embedded in such a way as 
to systematically affect offspring inflammation and brain development?  The Developmental 
Origins of Health and Disease (DOHaD) hypothesis posits that pre- and postnatal 
environmental exposures can influence long-term vulnerability for physical and mental health 
problems (Wadhwa, Buss, Entringer, & Swanson, 2009). One of the mechanistic drivers of 
these vulnerabilities is thought to be epigenetic alterations, such as DNA methylation 
(Gluckman et al., 2005). With regard to prenatal effects, few published studies exist that 
explicitly link prenatal adversity with DNA methylation specific to immune functioning and 
child mental health; however, mounting evidence suggests that prenatal adversity is 
associated with inflammatory response of cord blood monocytes of the neonate 
(Sureshchandra et al., 2017). More specifically, DNA methylation in cord blood has been 
associated with perinatal risks for immune-related disorders (such as asthma), including 
caesarean section (Schlinzig, Johansson, Gunnar, Ekström, & Norman, 2009), elevated levels 
of maternal immune markers (DeVries, Stern, Wright, & Vercelli, 2017), birth complications 
(Zhang et al., 2016), maternal cigarette smoking (van Otterdijk, Binder, & Michels, 2017) 
and diet (Lee et al., 2013). These data are consistent with a much larger group of studies 
showing that prenatal maternal depression, anxiety, nutrition and toxin exposure (e.g. 
cigarette smoking) are associated with changes in DNA methylation in the cord blood of 
new-borns (Barker, Cecil, et al., 2017; Binder & Michels, 2013; Cecil et al., 2017, in press; 
Oberlander et al., 2008; Richmond et al., 2015), which, in turn, can increase vulnerability for 
neurological (Monk et al., 2016) and mental health problems (Rijlaarsdam et al., 2017).   
  Emerging literature also suggests that exposure to adversity after birth can continue to 
affect DNA methylation in the immune system. For example, individuals born with lower 
birth weight and shorter duration of breast feeding show higher concentrations of CRP in 
adulthood (McDade et al., 2014; Tzoulaki et al., 2008) – DNA methylation may be involved. 
Indeed, major psychosocial stressors, such as child neglect, maltreatment, housing quality 
and poverty associate with DNA methylation in immune system genes (Cecil et al., 2016; 
Essex et al., 2013). More specifically, certain studies have examined cell cultures and 
shown that adversity-related DNA methylation in immune system genes can associate 
  




with the expression of both elevated and reduced plasma inflammatory biomarkers (e.g. 
McDade et al., 2017). Furthermore, in a study of adults (~ 20 years of age) who grew up 
in low income neighbourhoods, greater exposure to trauma and witnessing of 
community violence associated with lower levels of DNA methylation around the IL-6 
gene promoter, and in turn, a higher production of IL-6 in response to the Trier Social 
Stress test (Janusek, Tell, Gaylord-Harden, & Mathews, 2017) 
A recent study identified potential DNA methylation correlates of low-grade, chronic 
inflammation. Here, Ligthart et al. (2016) performed a epigenome-wide association of serum 
CRP in adults (~ 41 years of age). They reported 58 CpG sites (across 45 genes) that reliably 
replicated across a large European (n = 8863) discovery sample and African American (n = 
4111) replication sample. The researchers further characterised the molecular and clinical 
relevance of the CpG sites through examining associations with gene expression and clinical 
outcomes. However, Ligthart et al. (2016) did not examine associations with prenatal and 
postnatal adversity or with mental health outcomes, which is a main aim of the present study.  
The present study 
  Using prospective data drawn from a large population-based sample, prenatal and 
postnatal adversity, DNA methylation at birth, age 7 and ages 15-17, cognitive function at 
age 9 and internalising and externalising mental health problems spanning childhood to 
adolescence, the current study had three overall research aims. Firstly, to create and replicate 
an inflammation-related CRP epigenetic polygenic score (i-ePGS) biomarker of low-grade 
inflammation in a developmentally sensitive framework. Here we aimed to validate an i-
ePGS biomarker by associating DNA methylation of relevant loci at age 15-17 with serum 
CRP at ages 15 and 17 – importantly, this is the age when the DNA methylation resource and 
serum CRP samples overlapped. We then aimed to create i-ePGS scores at birth and age 7 to 
examine the degree to which i-ePGS scores correlated over time, thereby raising the 
possibility of a biomarker that could index chronic, low-grade inflammation early in the life 
course. Second, to examine if the i-ePGS biomarker associated with cognitive function and 
internalising and externalising symptoms, which would represent multifinality of outcome 
(Cicchetti & Rogosch, 1996). More specifically, we examined whether i-ePGS would 
negatively affect cognitive function, which, in turn, would then increase vulnerability for 
both internalising and externalising problems. The third overall aim was to examine pre- and 
postnatal adversity-related effects. With regard to prenatal effects, we tested if adversity in 
utero might indirectly associate with internalising and externalising problems, by way of 
affecting i-ePGS (at birth) and cognitive function.  With regard to postnatal effects, we 
  




similarly tested if postnatal adversity might indirectly associate with internalising and 
externalising problems, by way of affecting i-ePGS during childhood (age 7) and cognitive 
function.  
Methods 
Participants were drawn from the Accessible Resource for Integrated Epigenomics Studies 
(ARIES, www.ariesepigenomics.org.uk) (Relton et al., 2015), containing DNA methylation 
data for a subset of 1018 mother-offspring pairs and nested within the Avon Longitudinal 
Study of Parents and Children (ALSPAC).  ALSPAC is an ongoing epidemiological study of 
children born from 14,541 pregnant women residing in Avon, UK, with an expected delivery 
date between April 1991 and December 1992 (85% of eligible population) (Fraser et al., 
2013). Informed consent was obtained from all ALSPAC participants and ethical approval 
was obtained from the ALSPAC Law and Ethics Committee as well as Local Research 
Committees. The original ALSPAC sample is representative of the general population (Boyd 
et al., 2012). Please note that the study website contains details of all the data that is available 
through a fully searchable data dictionary: 
http://www.bris.ac.uk/alspac/researchers/dataaccess/data-dictionary/. For this study, we 
included youth from ARIES who had available data on symptomatology ratings (ages 7-15) 
as well as epigenetic data at birth (n =758, 50% male). The cohort profile of ARIES by 
(Relton et al., 2015) compared a selection of maternal characteristics in ARIES (n = 1018) to 
the rest of the ALSPAC sample. ARIES vs ALSPAC mothers were more ethnically 
homogenous (% white: ARIES = 100% vs ALSPAC 97.4%), slightly older (mean age: 
ARIES = 29.2 vs ALSPAC = 28.2), less likely to have a manual occupation (ARIES = 14% 
vs ALSPAC = 20.5%), and less likely to have smoked throughout pregnancy (ARIES = 9.7% 
vs ALSPAC = 19.4%). Otherwise, the subsample was considered to be reasonably 
representative of the main ALSPAC population. 
Measures 
Child cognitive function was measured at age 8 by the Wechsler Intelligence 
Scale for Children (WISC-III UK ; Weschsler, Golombok, & Rust, 1992). The WISC 
was administered to the children at an ALSPAC research clinic. A short form of the 
measure was employed to reduce the likelihood that the children would become fatigued 
and that this would affect their performance on the WISC. The WISC comprises five 
verbal subtests (Information, Similarities, Arithmetic, Vocabulary, Comprehension) 
and five performance subtests (picture completion, coding, picture arrangement, block 
design, object assembly).  We extracted the common variance between the verbal and 
  




performance tests in a latent factor of "cognitive function" in the overall model. We did 
so as we sought to tap the “true” score (i.e., the common variance) of “cognitive 
function,” while accounting for potential measurement error in the verbal and 
performance tests, respectively (see Brown, 2014).  Scores were age-normed in 
accordance with standard procedures. The distribution of verbal tests (M = 110.18, SD 
= 16.52, Skew =-0.002) and the performance tests (M = 101.81, SD = 16.99, Skew = -
0.054) were normal and within the range of age appropriate norms. 
 Internalising problems were assessed via mother ratings at ages 7, 10, 13 and 15 
years, using the well-validated Development and Well-Being Assessment interview 
(DAWBA) (Goodman, Heiervang, Collishaw, & Goodman, 2011). The DAWBA was 
administered via a computer-based package of package of questionnaires, interviews, and 
rating techniques used to assess adolescent psychopathology based on DSM-IV criteria. Each 
question was introduced with the stem: ‘over the last 6 months, and as compared with other 
children the same age, has s/he often….’ followed by the specific clause. The response 
categories were 0 = ‘no more than others’, 1 = ‘a little more than others’ and 2 = ‘a lot more 
than others’.  For depression, 12 symptoms were assessed including: ‘very sad’, ‘lost 
interest’, and ‘lost or gained weight’. For generalised anxiety, 7 symptoms were assessed 
including: ‘worried about own behavior, ‘worried about health’, and ‘worried about future’. 
For both anxiety and depression, scales, per age, were summed and then used to create an 
overall latent variable that indexed common variance in internalising problems across time. 
Externalising problems (ADHD, CD, ODD) were also assessed via maternal ratings 
on the DAWBA at ages 7, 10, 13 and 15 years. ADHD comprised 18 symptoms including: 
‘often fidgets’, ‘blurted out answers before hearing questions properly’, ‘does not listen’, and 
‘avoids things involving thought’. For ODD 9 symptoms were assessed, including: ‘has 
temper outbursts’, ‘has been touchy or easily annoyed’, ‘argued with grown-ups’ and ‘taken 
no notice of rules/refused to do as s/he is told’. For CD 8 symptoms were assessed, including: 
‘used a weapon’, ‘cruel to animals and birds’, and ‘stealing on the streets’. For all types of 
externalising behaviours, scales, per age, were summed and then used to create an overall 
latent variable that indexed common variance in externalising problems. 
Adversity exposure was assessed based on maternal reports. Risk items were 
organized into two developmental eras to reflect the timing of the i-ePGS scores (i) prenatal 
risks (18 weeks to 32 weeks) and (ii) early childhood risks (birth – age 7). For each 
developmental period, items were organized to create distinct but correlated risk domains: (i) 
Life events (e.g. death in family, accident, illness), (ii) Contextual risks (e.g. poor housing 
  




conditions, financial problems), (iii) Parental risks (e.g. parental psychopathology, criminal 
involvement and substance use), (iv) Interpersonal risks (e.g. intimate partner violence, 
family conflict), and (v) direct victimization (e.g. child bullied by peers or physically hurt; 
this measure of adversity exposure was specific to the postnatal risk composite). 
These adversity scores were previously estimated and validated by Cecil et al. (2014), 
who used confirmatory factor analyses to assess the internal reliability of the individual risk 
domains and extract one adversity score for each developmental era. Model fit was good: (i) 
Cumulative prenatal risk score: X2 (2) = .60, p = .73; (ii) Cumulative early childhood risk 
score: X2 (5) = 14.94, p = .01; CFI = .95; TLI = .90; RMSEA = .07, 90% CIs = .03, .12. In 
addition, we also incorporated – at the composite level – other risks pertinent to 
inflammation, including low birth weight (less than 2500 grams) to the prenatal adversity, 
and breastfeeding (1 = ‘no’ for first 6 months after birth, 0 = ‘yes’ in the first 6 months) and 
body mass index (at age 7) to the postnatal adversity index. Saved factor scores were used in 
all analyses.  
DNA methylation data. 500ng genomic DNA from blood (cord at birth; whole blood 
at age 7 and age 15-17yrs) was bisulfite-converted using the EZ-DNA methylation kit (Zymo 
Research, Orange, CA, USA). DNA methylation was quantified using the Illumina 
HumanMethylation450 BeadChip (HM450k; Illumina, USA) with arrays scanned using an 
Illumina iScan (software version 3.3.28). Samples or probes that failed quality control (>1% 
probes/samples with background detection p-value >= 0.05) were excluded from further 
analysis. Sex checks were performed using X/Y chromosome methylation. Genotype probes 
on the HM450k were compared between samples from the same individual and against SNP-
chip data to identify and remove any sample mismatches. Samples were quantile normalised 
using the dasen function within the wateRmelon package (version 1.4.0) in R. Normalization 
performance was evaluated using all three testing metrics in wateRmelon (genki assessing 
SNP-related probes, dmrse assessing imprinted probes and seabi, assessing gender 
differences).  Methylation levels were then indexed by beta values (corresponding to the ratio 
of the methylated signal divided by the sum of the methylated and unmethylated signal). 
Probes known to be cross-reactive or polymorphic (Chen et al., 2013; Price et al., 2013) and 
SNP (i.e. “rs”) probes were removed. We also removed participants with non-Caucasian or 
missing ethnicity (based on self-reports). Cell type proportions (CD8 T lymphocytes, CD4 T 
lymphocytes, natural killer cells, B lymphocytes, monocytes and granulocytes) for each 
participant were estimated using the reference-based approach detailed in Houseman et al. 
(2012). These cell types were controlled for at each time point (i.e., birth, age 7 and age 15-
  




17) in all analyses. In addition, for DNA methylation data at 15-17yrs, we also controlled for 
age.  
Analyses 
  Step 1: i-ePGS and validation. CRP-related probes were identified based on a recent 
epigenome-wide association study by Ligthart et al. (2016). We limited our selection to 7 
probes highlighted by Lightart et al. as these probes associated most strongly with the 
adversities and measures of cognitive function and mental health outcomes. Moreover, as can 
be seen in Table 1, 4 of these 7 these probes were found to associate with plasma CRP levels 
in both the discovery meta-analysis (9 cohorts, n =8,863) and a replication meta-analysis (4 
cohorts, n = 4111). Seven out of seven of the probes associated with whole blood cis gene 
expression levels. Seven out of seven of the probes associated at least one of the cardio-
metabolic phenotype of relevance to CRP (e.g. BMI, coronary heart disease, lipids, etc). We 
grouped the probes into a single i-ePGS. Specifically, we applied a method typically used for 
polygenic risk scores – that has recently been extended to epigenetic data (Shah et al., 2015) 
– where we multiplied the ALSPAC methylation values by their respective standardized 
regression betas (that is, weights) from the  Ligthart et al. (2016) EWAS, and then summed 
these weighted methylation values together into the i-ePGS. The use of weights ensured that 
the probes maintained their relative magnitude of association with CRP. We then validated 
the i-ePGS in ALSPAC by testing whether it significantly associated with measures of CRP 
at ages 15 and 17, as these are the ages where the i-ePGS and CRP overlap.  Once the i-ePGS 
at age 15-17 was characterized and validated, we then created the same i-ePGS risk measure 
at earlier time points, using DNA methylation data at birth and age 7. We then examined 
bivariate correlations amongst the inflammation-related epigenetic polygenic scores and 
between those scores and the measures of adversity, cognitive function, and 
psychopathology. 
 In this step we also examined, for each probe within the i-ePGS score, possible 
genetic influences on the level of methylation. We did so by searching the mQTLdb database 
(http://www.mqtldb.org). The mQTLdb database contains the results of a large-scale study 
based on ARIES data, characterizing genome-wide significant SNP effects on DNAm levels 
for all Illumina 450k probes (see Gaunt et al., 2016). 
  Step 2:  Associations between i-ePGS, cognitive function and outcomes. Here we 
examined a latent path analysis examining the inter-relations between i-ePGS, cognitive 
function and child externalising and internalising symptoms. In this step, we also examined 
  




the degree to which i-ePGS at birth might indirectly relate to internalising and/or 
externalising symptoms via an i-ePGS at age 7 and/or cognitive function at age 7.   
 Indirect pathways were programmed in model constraint statements in Mplus 
(Muthén & Muthén, 1998-2013). The indirect effects tested in this step assessed the extent 
to which i-ePGS might relate to higher internalising/externalising symptoms via cognitive 
function. Therefore, the indirect effects were defined by the product term of the pathways of 
interest (e.g., i-ePGS at birth to cognitive function BY cognitive function to internalising 
symptoms). Because standard errors underlying indirect effects (i.e. product terms) are 
known to be skewed, we bootstrapped all indirect effects 5,000 times with bias corrected 95% 
confidence intervals. The indirect pathways reported below are based on the bootstrapped 
variability around the product of non-standardized path coefficient estimates. 
  Step 3: Associations between adversity, i-ePGS cognitive function and outcomes. 
In this step, we tested the prenatal and postnatal effects by including the adversity scores 
(prenatal, postnatal). This enabled us to trace the inter-relationships between environmental 
exposures, the i-ePGS scores (birth, age 7), latent cognitive function (age 7), and the 
internalising and externalising (age 7-15) scores. For the prenatal effects, we expected i-ePGS 
at birth to associate with internalising and/or externalising scores indirectly via cognitive 
function at age 7. For postnatal effects, postnatal adversity would associate with 
internalising and/or externalising problems indirectly via i-ePGS and cognitive function 
at age 7. Indirect effects were estimated in identical fashion as step 2.  
   Path analyses were conducted using Mplus version 7.11 (Muthén & Muthén, 1998-
2013). Model fit was determined through the Comparative Fit Index and Tucker-Lewis Index 
(CFI & TLI; acceptable fit => 0.90) (Bentler & Bonett, 1980) and root mean square error of 
approximation (RMSEA; acceptable fit =< 0.08) (Browne & Cudeck, 1993). Maximum 
likelihood estimation with robust standard errors was used to estimate the model parameters, 
and missing data were handled through full information maximum likelihood. All analyses 
were conducted using SAS v9.4 (ref) and Mplus v7.11 (Muthén & Muthén, 1998-2016) 
Missing data 
  For the 1018 families within the ARIES resource, 914 had the required methylation 
data available from cord blood. Twenty-five samples at birth failed quality control (>1% 
probes/samples with background detection p-value ≥ 0.05) and were excluded from further 
analysis. From the resulting cord blood sample of 889, participants with  missing 
ethnicity were removed (n= 61). This resulted in a final total of 828 cord blood at birth. We 
included participants with data for the CRP, DAWBA symptoms, risk factors and DNA 
  




methylation. This resulted in a sample of 785 youth. We compared the 785 to the 828 on the 
study variables (i.e. prenatal risks and DAWBA symptoms) and found no significant 
differences. 
                                                                      Results 
Step 1: i-ePGS score validation. 
   Table 1 contains the 7 probes from Ligthart et al. (2016) described above (see Table 
1, supporting information, for total probe information). As can be seen, these probes were 
annotated to 9 total genes. For most genes, peripheral expression was higher than central 
nervous system expression; however, certain of these genes (e.g. TUBB) show moderate 
expression in the brain (see Table 2, supporting information). One probe cg10636246 
showed evidence of mQTL (i.e. DNA . Associations between the i-ePGS at age 15-17 and 
CRP levels at ages 15 and 17 were examined, as this was the age and time-span of 
overlapping DNAm and CRP. CRP associated with i-ePGS at age 15 r = -0.111, p < 0.002 
and age 17 r = -0.181, p < 0.0001. We then created i-ePGS scores at earlier time points (i.e. 
birth, age 7). i-ePGS at age 15-17 auto-correlated with i-ePGS at age 7 (r = 0.314, p < 
0.0001) and birth (r = 0.175, p < 0.0001). To aid in the interpretation of environmental and 
phenotypic association with the i-ePGS, we took the inverse value of the i-ePGS. This 
transformation made the i-ePGS consistent with the direction of higher CRP for potential 
low-grade chronic inflammation. As can be seen in Table 2, i-ePGS at birth and age 7 
differentially associated with the study variables.   
 Step 2: Associations between i-ePGS, cognitive function and outcomes 
  Prior to describing the latent path model, we first highlight certain bivariate 
correlations between the mental health outcomes and the study variables (see Table 2). First, 
we found that both internalising and externalising symptoms associated negatively with 
cognitive function; internalising (but not externalising) problems associated with i-ePGS at 
age 7; and neither outcome associated with i-ePGS at birth.  Second, cognitive function 
associated negatively with i-ePGS at birth, and the prenatal and postnatal adversity indexes. 
As stated earlier, i-ePGS at birth associated with a i-ePGS at age 7. We note also that cell 
type and sex each associated with i-ePGS (birth and age 7), and that sex associated with 
higher internalising (females > males) and externalising symptoms (females < males) (age 7-
15).   
 Figure 1 contains the latent path model that showed adequate fit to the data: χ2 (39) = 
77.395, p < 0.001; CFI = 0.972; TLI = 0.954; RMSEA = 0.035, 90% CI = 0.024, 0.047. Only 
  




significant pathways are shown, full model estimates are available in Supplemental 
Information (Figure SI_1). As can be seen, the associations described above largely 
remained significant after accounting for the other parameters in the model as well as cell 
type and sex. For example, i-ePGS at birth associated with both i-ePGS age 7 and lower 
cognitive function. i-ePGS at age 7 associated with higher internalising, but not externalising 
to symptoms. Higher cognitive function associated with lower levels of both internalising and 
externalising symptoms. Moreover, indirect effects showed that i-ePGS at birth associated 
with higher internalising (b = 0.020, 95% CI = 0.002, 0.069) and externalising (b = 0.029, 
95% CI = 0.003, 0.087) symptoms via lower cognitive function; and with higher internalising 
symptoms (b = 0.032, 95% CI = 0.011, 0.064) but not externalising symptoms (b = 0.005, 
95% CI = -0.011, 0.029) via continuity of i-ePGS at age 7.  
 Step 3: Associations between adversities, i-ePGS, cognitive function and outcomes.    
         In this step we added the prenatal (18-32 wks) and postnatal (birth – age 7) adversity 
scores and tested the prenatal and postnatal effects. Table 2 contains the correlations. At the 
bivariate level, pre- and postnatal adversity associated with internalising and externalising 
symptoms, and cognitive function. Postnatal, but not prenatal, adversity associated with i-
ePGS at age 7.  
 Figure 2 contains the overall latent path model, which showed adequate fit to the 
data: χ2 (51) = 96.122, p < 0.001; CFI = 0.968; TLI = 0.947; RMSEA = 0.034, 90% CI = 
0.023, 0.044. To decrease the complexity of Figure 2, only significant parameters are shown. 
Three results are highlighted here. First and foremost, as evidenced in the bivariate 
associations (and against our expectation), i-ePGS at birth did not associate with prenatal 
global adversity; we therefore have not included this variable in the model (see 
Supplemental Information Figure SI_2 for complete model estimates). Second, consistent 
with our expectation, postnatal adversity (birth – age 7) associated with higher i-ePGS at age 
7, which, in turn, associated with internalising symptoms (age 7-15). Third, with the addition 
of adversity, two associations in the first model (Figure 1) changed due to the new 
conditional relationships. The association between higher i-ePGS at age 7 and lower 
cognitive function (age 7) increased in strength of association – and the association between 
higher cognitive function (age 7) and lower internalising symptoms (age 7-15) decreased in 
strength of association.  
 On the one hand, these results suggest that the prenatal effects pathway does not 
involve the prenatal adversity index, but are confined to i-ePGS at birth, which might be a 
proxy for both unmeasured environmental effects during pregnancy and genetic influence 
  




(i.e. heritability) of immune system function. On the other hand, the data provides relatively 
straightforward support for postnatal effects, given that postnatal adversity associated with i-
ePGS at age 7.  Three indirect effects were identified: i-ePGS at birth associated with lower 
cognitive function, which, in turn, associated with higher externalising symptoms (b = 0.0.24; 
95% CIs = 0.002, 0.078); higher i-ePGS at age 7, which, in turn associated with higher 
internalising symptoms (b = 0.030; 95% CIs = 0.003, 0.063); and postnatal adversity (birth – 
age 7) associated with higher i-ePGS at age 7, which, in turn, associated with higher 
internalising symptoms (b = 0.009; 95% CIs = 0.002, 0.022). 
Discussion 
 In this prospective birth cohort study, we created and validated inflammation-related 
epigenetic risk scores (i.e. i-ePGS) and then tested prenatal and postnatal hypotheses about 
child and adolescent mental health. There were two indirect effects stemming from i-ePGS at 
birth: one to higher externalizing problems (7-15 years) via lower cognitive function (age 7), 
and the other to higher internalising problems (7-15 years) via higher i-ePGS at age 7. These 
indirect pathways suggest multifinality – that a single risk factor can associate with multiple 
outcomes through different developmental pathways (Cicchetti & Rogosch, 1996). We also 
identified one postnatal effect where adversity (birth to age 7) associated with higher 
internalising problems (7-15 years) via higher i-ePGS at age 7. Our findings are consistent 
with previous research showing associations between early life adversity, inflammation-
related DNAm and vulnerability for mental health (Janusek et al., 2017; McDade et al., 
2014). The present findings expand this literature in three main ways.  
 First, as mentioned, we were interested in the potential role of immune system-related 
DNA methylation in influencing cognitive function and mental health. We focused on CRP, 
as it is an acute-phase protein marker of systemic inflammation produced in response to 
increasing levels of circulating inflammatory factors (Mitchell & Aneshensel, 2017). In 
addition, serum CRP-related DNA methylation has recently been reported in an epigenome-
wide association study by Ligthart et al. (2016), which was based on multiple adult cohorts.  
Based on these results, we created an i-ePGS score and (partially) replicated Ligthart et al. 
(2016): the i-ePGS score associated with overlapping measures of serum CRP at age 15-17. 
Taking this as acceptable validation, we then created i-ePGS scores at birth and age 7. 
 Our second main finding was in the longitudinal associations between the i-ePGS 
scores and study variables. In the Developmental Origins of Health and Disease hypothesis, 
DNA methylation is suggested as a biological mechanism that can establish early 
vulnerability for subsequent mental and physical health problems(Monk et al., 2016). Here, 
  




for the first time, we show a new candidate mechanism: i-ePGS. Specifically, we found that 
i-ePGS at birth associated with lower cognitive function, which, in turn, associated with 
higher externalizing problems. This indirect effect is noteworthy as most research has 
reported direct associations between peripheral inflammation markers and internalizing, but 
not externalizing, problems (Danese & Baldwin, 2017). However, it is worth noting that a 
recent epigenome-wide association study reported variation in DNA methylation in cytokine-
related genes in adults with a history of chronic childhood physical aggression (Provençal et 
al., 2014). Indeed, the neuroimmune network hypothesis (Nusslock & Miller, 2016) posits 
that peripheral inflammation can indeed associate with externalizing problems by way of 
affecting executive control-related processes linked to the prefrontal cortex, such as executive 
control, decision making, and regulating threat- and reward-related tendencies (see also 
Danese & Lewis, 2016; Hostinar, Nusslock, & Miller, 2017). Of interest, our measure of 
cognitive function (i.e. the WISC-III) was comprised of verbal subtests (e.g. vocabulary, 
comprehension, etc.) and performance subtests (e.g. block design, object assembly, etc.). 
These aspects of cognitive function have been associated with both infection/immune 
functioning (Jensen, Berens, & Nelson 3rd, 2017) and externalising behaviours (Barker et al., 
2007; Loeber et al., 2012). Hence, the present results highlight the potential of inflammation 
associating with externalising problems via cognitive function.  
 The age 7 i-ePGS directly associated with internalizing problems, which, as stated, 
supports a range of research that has shown inflammation to associate with depressive 
symptoms, anxiety and post-traumatic stress disorder (Danese & Baldwin, 2017). The 
differences between this present study and those former studies are that (i) the association 
was not contingent on individuals being clustered by exposure to adversity (e.g. see Danese et 
al., 2011; Miller et al., 2002); and (ii) we examined an i-ePGS biomarker that is associated 
with CRP. Why would i-ePGS associate with higher internalizing problems, or lower 
cognitive function, for that matter? Although highly speculative, the genetic annotation of the 
different CpGs in the i-ePGS may help in interpreting these associations. For example, 
cg18181703 is annotated to TUBB, a complex locus involved in the structural component of 
microtubules, mutations of which are reported to associate with aberrant neural development 
(Breuss et al., 2012). Of interest, this gene is expressed in peripheral samples, but also in the 
brain, bone marrow, lymphocytes and placental tissue (Fagerberg et al., 2014). TUBB may 
therefore be a gene involved in both prenatal and postnatal inflammatory effects on neural 
development and brain-based mental health problems. These associations, as well as the i–
ePGS scores themselves, should be considered preliminary and in need of replication.  
  




The third main finding is regarding the prenatal and postnatal adversity-related 
hypotheses. Against expectation, prenatal adversity did not associate with the i-ePGS at birth. 
On the one hand, this null result may indicate that we did not assess the correct types of 
immunity-related prenatal adversities (e.g. maternal obesity); or that CRP-related methylation 
changes do not capture the influence of prenatal adversities on the immune system. Indeed, 
there are many other immune markers that could be examined. For example, interleukin-8, 
which can coincide or precede an increase in CRP, is shown to have specific T cell 
effector (i.e. proinflammatory) functions in neonates but not adults (Gibbons et al., 
2014). On the other hand, i-ePGS at birth may have a strong heritable component above and 
beyond environmental influence. Indeed CRP is estimated to be moderately heritable (40%; 
Baldwin et al., 2017; Pankow et al., 2001) and latent genetic risk can explain up to 15% of 
serum CRP variability (Baldwin et al., 2017). Moreover, a large-scale genome-wide 
association study (Dehghan et al., 2011) developed a weighted genetic risk score (similar to 
the weighted i-ePGS examined here) that was strongly associated with CRP levels. Another 
genome-wide association study identified genetic pathways related to immune system 
functioning for several types of mental health disorders (Network & Consortium, 2015). 
Although we identified genetic influence (i.e. mQTL) on DNAm levels in one of the CpGs 
included in the i-ePGS score, for this type of analysis to be more informative we would need 
to also show that the SNP (rs11667764) is influential in cognitive function or internalising 
symptoms, which we were unpowered to do. However, rs11667764, associates with variation 
in putamen and thalamus volume (Hibar et al., 2015), so it may be a SNP that is worthwhile 
of further examination.  
It is of great interest that the postnatal global adversity index (birth – age 7) associated 
with i-ePGS at age 7, which in turn, associated with internalizing problems (age 7-15). This 
finding supports the ‘cumulative’ adversity  hypothesis (see Danese & Baldwin, 2017), where 
repeated exposures of stressful events can become embedded in the epigenetic functioning of 
the immune system (Janusek et al., 2017), which can eventually manifest as chronic, low-
grade inflammation (McDade et al., 2017) and vulnerability for mental health problems. Also 
of note, however, is that this pathway did not include the measure of cognitive function. A 
recent meta-analysis has reported that the type of measure employed here may index 
impaired cognitive function that is concurrent to, but not predictive of, internalizing 
symptoms (see Scult et al., 2017) – which brings up the possibility that a different measure of 
brain function may be more appropriate. The neuroimmune network hypothesis, for example, 
highlights sensitivity to rewards and reward-related brain function in networked cortico-basal 
  




ganglia regions, as the most highly relevant for internalizing problems (Hostinar et al., 2017). 
Future research may want to examine dampened reward sensitivity as a risk for future 
internalizing problems.  
Findings should be interpreted in light of a number of limitations. First, the current 
study was based on a modestly sized population-based sample of youth. In the future, it will 
be important to test the robustness of findings using other epidemiological cohorts. Second, 
the study focused exclusively i-ePGS as a proxy for CRP; additional research is needed to 
establish that these i-ePGS scores are indeed developmentally sensitive, by way of examining 
CRP associations at each age. Third, findings were based on a certain measure of cognitive 
function (i.e. WISC-III) that has previously been associated with both internalising and 
externalising problems. Therefore, research will be needed to establish the relevance of the 
present findings to both brain structure and function, as well as other measures of cognitive 
function. Fourth, despite the fact that we identified prospective associations between i-ePGS 
and internalising and externalising problems, it is not possible to establish causality, as 
associations could reflect the contribution of confounding genetic and environmental 
influences. Fifth, adversity can associate with inflammatory response through bidirectional 
interactions between the immune system and the neuroendocrine stress axes. Animal research 
has shown that, for instance, prolonged stress can lead to an attenuation of the anti-
inflammatory properties of glucocorticoid and contribute to chronic low grade inflammation 
(Miller, Chen, & Parker, 2011). It will be important for future research to examine how the 
neuroendocrine stress system might further inform the present results.
  




              Table 1. DNAm sites used in the i-ePGS score: Associations with CRP and gene expression from the original study, with the addition of mQTLs  
 
    Methylation-CRP                        
(discovery sample) 

















cg10636246 AIM2 -0.0069 -12.37 3.89E-35 11.01 3.40E-28 No 
 






cg19821297 FGD2 -0.0031 -4.30 1.73E-05 -0.29 0.77 No 
 
cg27023597 HEATR6 -0.005 -4.08 4.51E-05 1.89 0.06 No 
 
cg06126421 IER3 -0.0052 -3.98 6.90E-05 -1.39 0.16 No 
  
 IFI16 -0.0069 -6.90 5.07E-12 6.47 9.90E-11  
 
cg06690548 SLC7A11 -0.0048 -6.96 3.34E-12 4.90 9.80E-07 No 
 






























Table 2. Bivariate correlations underlying the latent path analytic models (n = 785)   
 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1.   Internalising Problems (ages 7-15) 1           
 
2.   Externalising Problems  (ages 7-15) 0.390* 1          
 
3.   Cognitive Function (age 7) -0.151* -0.223* 1         
 
4.   ePGS (birth) -0.037 0.069 -0.098* 1        
 
5.   ePGS (age 7) 0.151* 0.036 0.025 0.201* 1       
 
6.   ePGS   (age 15-17) 0.008 -0.002 0.017 0.175* 0.314* 1      
 
7.   Prenatal Adversity (18-32 wks)  0.145* 0.239* -0.109 0.042 -0.041 -0.067 1     
 
8.   Postnatal Adversity (birth - age 7) 0.215* 0.156* -0.077 0.008 0.103* 0.005 0.179* 1    
 
9.   Sex (1=female, 0=male)  0.104* -0.152* -0.028 -0.211* -0.151* -0.34* -0.024 -0.004 1   
 
10.   Cell Type (birth) -0.024 0.043 -0.06 0.635* 0.144* 0.136* 0.015 0.003 -0.144* 1  
 

























Note. Absolute value of i-ePGS score is depicted in this graph, to mirror direction of CRP (higher) based on previous DNAm immune studies (Janusek 
et al., 2017; Ligthart et al., 2016); non-shaded area = study variables; shaded area = control variables; i-ePGS = epigenetic risk scores; *  p  < 0.05. 
  





Figure 1. Latent path analytic model: Associations between i-ePGS, cognitive function and 
internalising and externalising symptoms 
 
Note. i-ePGS = inflammation-related epigenetic risk score; inverse value of i-ePGS score is 
depicted in this graph to mirror direction of CRP (higher) based on previous DNAm 
immune studies (Janusek et al., 2017; Ligthart et al., 2016); only significant pathways 
shown; Int = internalising symptoms; Ext = externalising symptoms; Cogn Funct = 
cognitive function; Dep = depression symptoms; Anx = anxiety symptoms; ADHD = 
attention deficit hyperactivity disorder symptoms; CD = conduct disorder symptoms; ODD 
= oppositional defiant disorder symptoms;  
  
  




Figure 2. Latent path analytic model: Associations between cumulative risk score, i-
ePGS, cognitive function and internalising and externalising symptoms 
 
Note. i-ePGS = inflammation-related epigenetic risk score; inverse value of i-ePGS score is 
depicted in this graph to mirror direction of CRP (higher) based on previous DNAm immune 
studies (Janusek et al., 2017; Ligthart et al., 2016); only significant paths shown; * = p  < 
0.05; Int = internalising symptoms; Ext = externalising symptoms; Cogn Funct = cognitive 
function; Dep = depression symptoms; Anx = anxiety symptoms; ADHD = attention deficit 
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